pamidronate has been researched along with Angiogenesis, Pathologic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 18 cases of osteonecrosis were recorded in the group administered pamidronate and dexamethasone." | 7.76 | An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats. ( Camacho-Alonso, F; Gómez-García, F; López-Jornet, P; Molina-Miñano, F; Vicente-Ortega, V, 2010) |
| "A total of 18 cases of osteonecrosis were recorded in the group administered pamidronate and dexamethasone." | 3.76 | An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats. ( Camacho-Alonso, F; Gómez-García, F; López-Jornet, P; Molina-Miñano, F; Vicente-Ortega, V, 2010) |
| "Neovascularisation and bone resorption are related to myeloma disease activity." | 1.32 | Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease. ( Angelopoulou, MK; Dimopoulou, MN; Gribabis, DA; Kokoris, SI; Kyrtsonis, MC; Pangalis, GA; Siakantaris, MP; Vassilakopoulos, TP, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Jornet, P | 1 |
| Camacho-Alonso, F | 1 |
| Molina-Miñano, F | 1 |
| Gómez-García, F | 1 |
| Vicente-Ortega, V | 1 |
| Kyrtsonis, MC | 1 |
| Vassilakopoulos, TP | 1 |
| Siakantaris, MP | 1 |
| Kokoris, SI | 1 |
| Gribabis, DA | 1 |
| Dimopoulou, MN | 1 |
| Angelopoulou, MK | 1 |
| Pangalis, GA | 1 |
2 other studies available for pamidronate and Angiogenesis, Pathologic
| Article | Year |
|---|---|
An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats.
Topics: Animals; Bone Density Conservation Agents; Dexamethasone; Diphosphonates; Drug Combinations; Glucoco | 2010 |
Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin | 2004 |